Cost of diabetic foot disease to the National Health Service in England

Diabetic Medicine

Volumn 31, Issue 12, 2014, Pages 1498-1504

  Kerr, M ^a   Rayman, G ^b   Jeffcoate, W J ^c  

^a Economic Insight Limited   (United Kingdom)

^b IPSWICH HOSPITAL NHS TRUST   (United Kingdom)

^c NOTTINGHAM UNIVERSITY HOSPITALS NHS TRUST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMPUTATION; ARTICLE; COMMUNITY CARE; COST OF ILLNESS; DIABETIC FOOT; FOOT ULCER; HEALTH CARE COST; HEALTH CARE UTILIZATION; HIGH RISK PATIENT; HOSPITAL ADMISSION; HUMAN; LENGTH OF STAY; MULTIVARIATE ANALYSIS; NATIONAL HEALTH SERVICE; OUTPATIENT CARE; PRIMARY MEDICAL CARE; SECONDARY HEALTH CARE; UNITED KINGDOM; AFTERCARE; BUDGET; ECONOMICS; HOSPITALIZATION; PRIMARY HEALTH CARE; REGRESSION ANALYSIS;

ANTIINFECTIVE AGENT;

AFTERCARE; AMPUTATION; ANTI-BACTERIAL AGENTS; BUDGETS; DIABETIC FOOT; ENGLAND; HEALTH CARE COSTS; HOSPITALIZATION; HUMANS; LENGTH OF STAY; MULTIVARIATE ANALYSIS; PRIMARY HEALTH CARE; REGRESSION ANALYSIS; STATE MEDICINE;

EID: 84911407764     PISSN: 07423071     EISSN: 14645491     Source Type: Journal    
DOI: 10.1111/dme.12545     Document Type: Article

References (32)

1. Kumar S, Ashe HA, Parnell LN, Fernando DJ, Tsigos C, Young RJ et al. The prevalence of foot ulceration and its correlates in type 2diabetic patients: a population-based study. Diabet Med 1994; 11: 480-484.
2. Walters DP, Gatling W, Mullee MA, Hill RD. The distribution and severity of diabetic foot disease: acommunity study with comparison to a non-diabetic group. Diabet Med 1992; 9: 354-358.
3. Leese GP, Stang D, McKnight JA, Scottish Diabetes Foot Action Group. A national strategic approach to diabetic foot disease in Scotland: changing a culture. Br J Diabetes Vasc Dis 2011; 11: 69-73.
4. Jeffcoate WJ, Price PE, Phillips CJ, Game FL, Mudge E, Davies S et al. Randomised controlled trial of the use of three dressingpreparations in the management of chronic ulceration of the foot in diabetes. Health Technol Assess 2009;13(54).
5. Ragnarson Tennvall G, Apelqvist J. Health-related quality of life in patients with diabetes mellitus and foot ulcers. J Diabetes Complications 2000; 14: 235-241.
6. Apelqvist J, Larsson J, Agardh CD. Long-term prognosis for diabetic patients with foot ulcers. J Intern Med 1993; 233: 485-491.
7. Moulik PK, Mtonga R, Gill GV. Amputation and mortality in new-onset diabetic foot ulcers stratified by etiology. Diabetes Care 2003; 26: 491-494.
8. Icks A, Scheer M, Morbach S, Genz J, Haastert B, Giani G et al. Time-dependent impact of diabetes on mortality in patients aftermajor lower extremity amputation: survival in a population-based 5-year cohort in Germany. Diabetes Care 2011; 34: 1350-1354.
9. Ikonen TS, Sund R, Venermo M, Winell K. Fewer major amputations among individuals with diabetes inFinland in 1997-2007: a population-based study. Diabetes Care 2010; 33: 2598-2603.
10. Jeffcoate WJ, Chipchase SY, Ince P, Game FL. Assessing the outcome of the management of diabetic foot ulcers using ulcer-related and person-related measures. Diabetes Care 2006; 29: 1784-1787.
11. Armstrong DG, Lavery LA, Harkless LB. Validation of a diabetic wound classification system. Thecontribution of depth, infection, and ischemia to risk of amputation. Diabetes Care 1998; 21: 855-859.
12. Holman N, Young RJ, Jeffcoate WJ. Variation in the recorded incidence of amputation of the lower limb in England. Diabetologia 2012; 55: 1919-1925.
13. Ince P, Kendrick D, Game F, Jeffcoate W. The association between baseline characteristics and theoutcome of foot lesions in a UK population with diabetes. Diabet Med 2007; 24: 977-981.
14. Margolis DJ, Allen-Taylor L, Hoffstad O, Berlin JA. Diabetic neuropathic foot ulcers: the association of wound size, wound duration, and wound grade on healing. Diabetes Care 2002; 25: 1835-1839.
15. Kerr M. Foot Care for People with Diabetes: The Economic Case for Change, NHS Diabetes, 2012. Available at: https://www.diabetes.org.uk/Documents/nhs-diabetes/footcare/footcare-forpeople-with-diabetes.pdf. Last accessed 19 April 2014.
16. Curtis L. Unit Costs of Health and Social Care 2011. Personal Social Service Research Unit, 2011. Available at: http://www.pssru.ac.uk/project-pages/unit-costs/2011/ Last accessed 8 July 2014.
17. British National Formulary 62, September 2011, British Medical Association, Royal Pharmaceutical Society. London: Pharmaceutical Press, 2011.
18. NHS Payment by Results 2010-11 National Tariff. Available at: http://data.gov.uk/dataset/payment-by-results-2010-11-national-tariff-information. Last accessed 24 May 2013.
19. NHS reference costs 2010-11, Department of Health. Available at: https://www.gov.uk/government/publications/2010-11-reference-costs-publication. Last accessed 24 April 2013.
20. The Amputee Statistical Database for the United Kingdom 2006/07 Information Services Division, NHS Scotland on behalf of National Amputee Statistical Database (NASDAB) 2009.
21. Piaggesi A, Macchiarini S, Rizzo L, Palumbo F, Tedeschi A, Nobili LA et al. An off-the-shelf instant contact casting device for the management of diabetic foot ulcers: a randomized prospective trial versus traditional fiberglass cast. Diabetes Care 2007; 30: 586-590.
22. NHS reference costs 2009-10, Department of Health. Available at: https://www.gov.uk/government/publications/nhs-reference-costs-2009-2010. Last accessed 31 January 2014.
23. Ince P, Abbas ZG, Lutale JK, Basit A, Ali SM, Chohan F et al. Use of the SINBAD classification system and score in comparing outcome of foot ulcer management on three continents. Diabetes Care 2008; 31: 964-967.
24. Oyibo SO, Jude EB, Tarawneh I, Nguyen HC, Harkless LB, Boulton AJ. A comparison of two diabetic foot ulcer classification systems: the Wagner and the University of Texas wound classification systems. Diabetes Care 2001; 24: 84-88.
25. Lavery LA, Armstrong DG, Peters EJG. Probe-to-bone test for diagnosing diabetic foot osteomyelitis: reliable or relic? Diabetes Care 2007; 30: 270-274.
26. Shone A, Burnside J, Chipchase S, Game F, Jeffcoate W. Probing the validity of the probe-to-bone test in the diagnosis of osteomyelitis of the foot in diabetes. Diabetes Care 2006; 29: 945.
27. National Diabetes Audit 2010-11 Report 2: Complications and Mortality, Health and Social Care Information Centre, 2012.
28. Quality and Outcomes Framework, Health and Social Care Information Centre. Available at: http://www.hscic.gov.uk/qof. Last accessed 24 April 2013.
29. National Diabetes Inpatient Audit 2011, Health and Social Care Information Centre 2012.
30. Whitston M, Chung S, Henderson J, Young B. What can be learned about the impact of diabetes on hospital admissions from routinely recorded data? Diabet Med 2012; 29: 1199-1205.
31. Simmons D, Wenzel H. Diabetes inpatients: a case of lose, lose, lose. Is it time to use a 'diabetes-attributable hospitalization cost' to assess the impact of diabetes? Diabet Med 2011; 28: 1123-1130.
32. Game FL, Catlow R, Jones GR, Edmonds ME, Jude EB, Rayman G et al. Audit of acute Charcot's disease in the UK: the CDUK study. Diabetologia 2012; 55: 32-35.